BridgeBio Pharma Inc logo

BBIO - BridgeBio Pharma Inc News Story

$49.13 2.7  5.7%

Last Trade - 11/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.19bn
Enterprise Value £5.51bn
Revenue £6.16m
Position in Universe 1120th / 6853

BRIEF-BridgeBio Says Amended Co's Loan And Security Agreement Dated June 19, 2018

Thu 15th April, 2021 10:29pm
April 15 (Reuters) - BridgeBio Pharma Inc  BBIO.O :
    * BRIDGEBIO PHARMA INC -  ON APRIL 13, 2021, AMENDED CO'S
LOAN AND
SECURITY AGREEMENT DATED JUNE 19, 2018
    * BRIDGEBIO PHARMA INC -  CREDIT AGREEMENT AMENDMENT, AMONG
OTHER
THINGS, EXTENDS INTEREST-ONLY PERIOD UNDER CREDIT AGREEMENT TO
JUNE 1, 2024
    * BRIDGEBIO PHARMA INC - CREDIT AGREEMENT AMENDMENT EXTENDS
MATURITY DATE FOR TERM LOANS UNDER CREDIT AGREEMENT TO MAY 1,
2025
    * BRIDGEBIO PHARMA INC -  INTEREST-ONLY PERIOD UNDER CREDIT
AGREEMENT MAY BE FURTHER EXTENDED TO JUNE 1, 2025, UNDER CERTAIN
CONDITIONS IN AMENDMENT
    * BRIDGEBIO PHARMA - MATURITY DATE FOR TERM LOANS UNDER
CREDIT
AGREEMENT MAY BE FURTHER EXTENDED TO MAY 1, 2026 UNDER CERTAIN
CONDITIONS OF AMENDMENT

Source text: (https://bit.ly/3snLTFO)
Further company coverage:  BBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.